Dehnen Dorothea, Milzkott Maia, Borchardt Benjamin, Graute Anette, Dehnen Katja, Herzer Kerstin, Willuweit Katharina, Herwig Anna, Rashidi-Alavijeh Jassin, Weltermann Birgitta
Institute of General Practice, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Knappschafts-Klinik Bad Neuenahr, Bad Neuenahr-Ahrweiler, Germany.
Clin Transplant. 2025 Oct;39(10):e70239. doi: 10.1111/ctr.70239.
Vaccination rates of immunosuppressed liver transplant recipients need to improve. We compared the effectiveness of a three-arm randomized intervention on vaccination rates in liver transplant recipients.
Two hundred and eighty-nine liver transplant recipients were randomly assigned to three groups: (1) patient intervention, (2) family physician intervention, and (3) combined patient and family physician intervention. The intervention consisted of a yellow information letter, which was personalized and sent to either the patient (1), the family physician (2), or both (3) in December 2016.
Irrespective of the assigned intervention group, a significant increase in vaccination rates from baseline to follow-up after 2 years was observed for tetanus (53%-56%), pertussis (52%-57%), hepatitis A (44%-49%), hepatitis B (64%-71%), pneumococci (68%-75%), and the sequential pneumococcal vaccination (12%-22%). Comparing the interventions, the vaccination rate for hepatitis A was significantly higher at follow-up for intervention (3) (OR = 9.07, p = 0.043) and (2) (OR = 9.91, p = 0.034) than for intervention (1). Concerning the vaccination rate for hepatitis B, an odds ratio of 9.13 was observed for intervention (2) (p = 0.006) compared to (1). Interventions (2) and (3) were generally superior to the patient-centered intervention alone, with the exception of influenza vaccination.
The results show the importance of family physicians in improving vaccination rates in liver transplant recipients. Establishing low-threshold communication channels, for example, via the electronic patient record, could improve cooperation between physicians in specialized outpatient clinics and family physicians.
German Clinical Trials Register (DRKS: DRKS00035422). Registration was done retrospectively due to time constraints and lack of human resources.
免疫抑制的肝移植受者的疫苗接种率有待提高。我们比较了一项三臂随机干预措施对肝移植受者疫苗接种率的有效性。
289名肝移植受者被随机分为三组:(1)患者干预组,(2)家庭医生干预组,以及(3)患者与家庭医生联合干预组。干预措施包括一封黄色的信息信,该信为个性化定制,于2016年12月发送给患者(1组)、家庭医生(2组)或两者(3组)。
无论分配到哪个干预组,2年后从基线到随访时,破伤风(53%-56%)、百日咳(52%-57%)、甲型肝炎(44%-49%)、乙型肝炎(64%-71%)、肺炎球菌(68%-75%)以及序贯肺炎球菌疫苗接种(12%-22%)的疫苗接种率均显著提高。比较各干预组,干预(3)组(OR = 9.07,p = 0.043)和(2)组(OR = 9.91,p = 0.034)在随访时甲型肝炎的疫苗接种率显著高于干预(1)组。关于乙型肝炎的疫苗接种率,干预(2)组与(1)组相比,优势比为9.13(p = 0.006)。除流感疫苗接种外,干预(2)组和(3)组总体上优于仅以患者为中心的干预组。
结果表明家庭医生在提高肝移植受者疫苗接种率方面的重要性。建立低门槛的沟通渠道,例如通过电子病历,可改善专科门诊医生与家庭医生之间的合作。
德国临床试验注册中心(DRKS:DRKS00035422)。由于时间限制和人力资源不足,注册为回顾性注册。